Randomized Phase IIa Trial of Purified Candida Antigen for Common Warts: Evaluating the Safety and Efficacy Across Multiple Dosing Regimens

Authors

Institutions

Publication Details

Journal
Dermatology and Therapy
Published
2025-03-29
DOI
https://doi.org/10.1007/s13555-025-01387-1
Citations
1
Primary Topic
Cervical Cancer and HPV Research
Type
article
Field-Weighted Citation Impact
1.35
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Randomized Phase IIa Trial of Purified Candida Antigen for Common Warts: Evaluating the Safety and Efficacy Across Multiple Dosing Regimens

Sandra Marchese Johnson, Henriette Svarre Nielsen, Stacy Smith, Robert E. Esch
1 citations
Dermatology and Therapy
Cervical Cancer and HPV Research
1.35
article

Randomized Phase IIa Trial of Purified Candida Antigen for Common Warts: Evaluating the Safety and Efficacy Across Multiple Dosing Regimens

Sandra Marchese Johnson, Henriette Svarre Nielsen, Stacy Smith, Robert E. Esch
article en
1 citations

Abstract

No abstract available for this paper.
Dermatology and TherapyVol. 15(5)
Freedom to Live (US), Nielsen Engineering & Research (United States) (US)
Good health and well-being
Openalex Percentile: Top 21%
Cervical Cancer and HPV Research
1.35
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Randomized Phase IIa Trial of Purified Candida Antigen for Common Warts: Evaluating the Safety and Efficacy Across Multiple Dosing Regimens — Sandra Marchese Johnson, Henriette Svarre Nielsen, et al. · Dermatology and Therapy (2025) | TGRS Research Map | TGRS